Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01212172 · ClinicalTrials.gov registry record · Phase 3
Comparison of Efficacy, Safety and Tolerability of Two Different 810 nm Diode Lasers for Hair Reduction
A Phase 3 study of Hypertrichosis, sponsored by University of California, Irvine.
- Completed
- Registry status
- Phase 3
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT01212172: Completed Phase 3 study of Hypertrichosis, sponsored by University of California, Irvine.
NCT01212172 is a Phase 3 study of Hypertrichosis that has completed, run by University of California, Irvine. The registered enrollment target is 20 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01212172, a Phase 3 study of Hypertrichosis, has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to compare two different 810 diode laser systems (Soprano XL (SHR Mode)and Light Sheer Duet) for laser hair removal. The goal is to determine if each laser system is effective at reducing the amount of hair on the lower legs or the axilla (arm pit). Another goal is determine the subject's perspective on the treatment including tolerability and effectiveness.
Primary Outcome
% reduction from baseline hair count at time points 1 month, 6 months and 12 months \[following last (5th laser) treatment\]
Conditions Studied
Interventions
- DEVICE Soprano/SHR
- DEVICE LightSheer
Study Locations (1)
California
- Department of Dermatology Clinical Research - Irvine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2010-09 |
| Est. Completion | 2013-09 |
| Phase | Phase 3 |
What the finished NCT01212172 record still lists
NCT01212172 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Hypertrichosis appearing as the primary indexed condition, and to 2 interventions - of which Soprano/SHR is the first listed.
NCT01212172 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01212172 about?
NCT01212172 is a clinical study titled "Comparison of Efficacy, Safety and Tolerability of Two Different 810 nm Diode Lasers for Hair Reduction". The purpose of this research study is to compare two different 810 diode laser systems (Soprano XL (SHR Mode)and Light Sheer Duet) for laser hair removal. The goal is to determine if each laser system is effective at reducing the amount of hair on the lower legs or the axilla (arm pit). Another goal...
What is the current status of trial NCT01212172?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 20 participants. The study started on 2010-09. Estimated completion is 2013-09.
What conditions does trial NCT01212172 study?
This clinical trial studies the following conditions: Hypertrichosis.
What interventions are being tested in trial NCT01212172?
The interventions under investigation include: Soprano/SHR (DEVICE), LightSheer (DEVICE).
Who is sponsoring clinical trial NCT01212172?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01212172 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertrichosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01212172's enrollment target sits among peer trials
20 1956th of 2000 higher than 32 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia